Metal Injection Molding is changing medical device manufacturing by enabling the production of intricate, high-quality ...

PERTH, Australia, March 17, 2026 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC ...

The pharmaceutical injectables market is gaining more traction as vaccines and the development of biological drugs such as cell and gene therapies grow. Multiple new therapy areas have emerged and ...

APEX, N.C., Jan. 16, 2026 /PRNewswire/ -- Apiject Holdings, Inc. today announced the signing of a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The ...

In response to evolving regulatory expectations, the industry is moving toward integrated, risk-based, and transparent ...

This reflects the confidence pharmaceutical innovators place in Pyramid’s expanded state-of-the-art facility to deliver ...

Discover why manufacturers are replacing traditional injection molding with 3D printed TPU to reduce tooling costs, speed up production, and improve flexibility.

A reformulated RLS-2201 is being produced at BioCina's sterile manufacturing facility in Perth, under conditions designed to confirm the reproducibility and robustness of the manufacturing process.

A reformulated RLS-2201 is being produced at BioCina’s sterile manufacturing facility in Perth, under conditions designed to confirm the reproducibility and robustness of the manufacturing process.